Sentrx Announces Partnership with Thomson Scientific: Drug Safety Firm will Incorporate Leading-Edge Literature Search Capabilities into Service Offerings

Share Article

Sentrx announced today that it has signed an agreement with Thomson ScientificÂ?s Custom Information ServicesSM group to deliver customized literature searches for adverse events. Sentrx will offer these capabilities as part of its Value-Added Services.

Sentrx, the leading provider of technology-enabled services and solutions for global drug safety, announced today that it has signed an agreement with Thomson Scientific’s Custom Information ServicesSM group, a business of The Thomson Corporation, to deliver customized literature searches for adverse events. Sentrx will offer these capabilities as part of its Value-Added Services.

Regulatory authorities, including the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA), require biopharmaceutical and medical device companies to search scientific and medical publications on a regular basis for any mention of adverse events associated with their marketed products. If one is found, the case must be investigated and reported to the appropriate agencies. The process is time-consuming and requires the skills of information specialists and health care professionals.

Thomson Scientific offers the most thorough and expedient method for literature review in the industry. Custom Information Services analyzes over 10,800 journals in the Thomson Scientific database using client-specific profiles, which contain information regarding a company’s products, therapeutic areas and other points of interest. Custom Information Service staff evaluate the initial results and identify relevant articles based on the company’s search criteria. An expert staff of information scientists then index and prepare customized abstracts or annotations to a company’s specifications. Custom Information Services delivers the finished product in whatever format is necessary for upload into any proprietary database, including physician or healthcare professional websites.

“Sentrx strives to optimize drug safety operations, and we have found that literature review is often performed inefficiently in the pharmaceutical industry,” said Joseph Albano, Chief Executive Officer of Sentrx. “Our partnership with Thomson Scientific helps us deliver best-of-breed processes and technology to our clients for an important practice in adverse event monitoring and reporting.”

“Pharmacovigilance and safety groups appreciate the value that CIS brings to literature review,” said Angus Metcalfe, Vice President for Pharma Chem Sales, Thomson Scientific. “We are pleased to expand our offerings to these clients to include the processing of adverse event cases identified during research related to their products.”

About Sentrx

Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to manage the safety risks associated with developing and marketing pharmaceuticals. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please visit their website at or call 1-888-399-8032, extension 261.

About The Thomson Corporation

The Thomson Corporation is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research and healthcare. With operational headquarters in Stamford, CT, Thomson has approximately 38,000 employees and provides services in approximately 130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific information solutions can be found at and include: ISI Web of Knowledge( SM)—facilitating discovery by offering seamless navigation to high-quality, multidisciplinary journal (Web of Science®), patent (Derwent World Patents Index®), and Web content, evaluation tools, and bibliographic management products (EndNote®); Thomson Pharma( SM)—an integrated information solution for the pharmaceutical and biotechnology markets; Delphion®—providing access to full-text patent documents from the world’s leading patent authorities; Techstreet—offering a wide variety of engineering codes and standards; and BIOSIS Previews ®—the world's most comprehensive reference database for life science research. For more information, please contact Rodney Yancey, Manager, Corporate Communications, Thomson Scientific by phoning +1 215 386-0100, ext. 1396, or by sending an email to

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jill Notte
Email >
Visit website